Advertisements As Well As Prescribing Information / Drug Label Seem To Downplay The Fact That There Is No Reversal Agent For Eliquis, Yet
SUMMARY: In print advertisements for their relatively new blood thinner medicine Eliquis, what you will not see is any statement to the effect that there is no reversal agent to stop a serious bleeding event that may happen while a patient is on Eliquis. That is, Bristol-Myers Squibb and Pfizer do not state in these advertisements that there is no FDA-approved antidote for Eliquis as regards its blood-thinner effect at this time.
Instead, these drug companies could perhaps tell all of us that the risk of death is higher once patients using Eliquis start to bleed due to a traumatic incident, or an unrecognized internal bleeding event, such as a gastrointestinal (GI) bleed.
Accordingly, it was good to see the recent news reports and a drug company press release that there are some apparent developments in getting an Eliquis antidote approved by the FDA and, ultimately, available for us with patients who need it.[Read this article in full at original source]
Strictly Confidential, No Obligation